HIDRADENITIS SUPPURATIVA
Clinical trials for HIDRADENITIS SUPPURATIVA explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for painful skin condition
Disease control Not yet recruitingThis study is testing a new drug called LAD191 for adults with moderate-to-severe hidradenitis suppurativa (HS), a painful skin condition. Researchers will compare different doses of LAD191 against a placebo and an existing drug (adalimumab) to see which is better at reducing the…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Massive italian study to map skin disease treatment patterns
Knowledge-focused Not yet recruitingThis study will analyze existing medical records from 20,000 Italian patients with psoriasis, eczema, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers aim to understand how these conditions are treated in real-world practice and how patients' health evolves ove…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: Fondazione ISIDE • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Could a skin drug help your heart? new study investigates
Knowledge-focused Not yet recruitingThis study aims to understand if secukinumab, a standard treatment for moderate-to-severe hidradenitis suppurativa (a painful skin condition), has any effect on the progression of plaque in the heart's arteries. It will follow 34 adults who are already at high risk for heart dise…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC